The Journal of Urology
Volume 175, Issue 2 , Pages 533-536, February 2006

A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer

  • E. David Crawford

      Affiliations

    • University of Colorado Health Sciences Center, Fort Collins, Colorado
    • Corresponding Author InformationCorrespondence: Section of Urologic Oncology, University of Colorado Health Sciences Center, P. O. Box 6510, Mail Stop F-710, Aurora, Colorado 80045 (telephone: 720-848-0195; FAX: 720-848-0203)
    • Financial interest and/or other relationship with Merck, Sanofi-Aventis, Celgene, Andrx/Auxilium, National Institutes of Health, University of Colorado Cancer Center, Oncura and Praecus.
    • ,
  • Oliver Sartor

      Affiliations

    • Louisiana State University, New Orleans, Louisiana
    • Financial interest and/or other relationship with Atrix Laboratories and Sanofi-Aventis.
    • ,
  • Franklin Chu

      Affiliations

    • San Bernardino Urological Associates, San Bernardino, California
    • ,
  • Ramon Perez

      Affiliations

    • Urology Health Center, New Port Richey, Florida
    • Financial interest and/or other relationship with Atrix Laboratories and Sanofi-Aventis.
    • ,
  • Gary Karlin

      Affiliations

    • Lawrenceville Urology, Lawrenceville, New Jersey
    • Financial interest and/or other relationship with Atrix Laboratories.
    • ,
  • J. Steve Garrett

      Affiliations

    • Aurora and Atrix Laboratories, Inc., Fort Collins, Colorado
    • Financial interest and/or other relationship with QLT USA.

Received 8 March 2005

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study informed consent received institutional review board approval.

PII: S0022-5347(05)00161-8

doi:10.1016/S0022-5347(05)00161-8

The Journal of Urology
Volume 175, Issue 2 , Pages 533-536, February 2006

Article Tools

* Image Usage & Resolution